Reported Tuberculosis in the United States, 2020
PAGE 2 of 8
‹View Table of Contents
State & Local Data
On This Page
Highlights
Reporting areas include:
- 50 U.S. states, New York City, and the District of Columbia (DC) unless otherwise specified,
- Five U.S. territories (American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Puerto Rico, and the U.S. Virgin Islands) and
- Three independent countries that are in compacts of free association with the United States (Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau).
As in past years, four U.S. states combined reported more than half of all U.S. TB cases in 2020:
- California (23.8%),
- Texas (12.3%),
- New York, including New York City (8.4%), and
- Florida (5.7%).
In 2020, the reporting areas with TB incidence rates (per 100,000 persons) above the national incidence rate (per 100,000 persons) included:
- Alaska; 7.9,
- Hawaii; 6.5,
- New York City; 5.4,
- California; 4.3,
- Texas; 3.0,
- New Jersey; 2.8,
- District of Columbia; 2.7, and
- Maryland; 2.5.
The incidence rates (per 100,000 persons) among the U.S. territories and freely associated states were:
- Republic of the Marshall Islands; 252.5
- Commonwealth of the Northern Mariana Islands; 75.2,
- Federated States of Micronesia; 73.7,
- Republic of Palau; 50.0,
- Guam; 33.8,
- American Samoa; 6.3,
- U.S. Virgin Islands; 3.8, and
- Puerto Rico; 0.8.
Source: TB by Reporting Areas: 2020 and 2019
Learn more in the Executive Commentary.
- TB by Reporting Areas: 2020 and 2019
- TB Ranked and Grouped by Number of Cases: Reporting Areas, 2020 and 2019
- TB by Pulmonary and Extrapulmonary Disease: Reporting Areas, 2020
- Primary Reason for TB Evaluation: Reporting Areas, 2020
- TB by Metropolitan Statistical Areas with ≥500,000 Population, 2020 and 2019
- TB Among Non-U.S.–Born Persons by Years in the United States: 1993–2020
- TB by Age Group: Reporting Areas, 2020
- TB by Hispanic Ethnicity and Race: Reporting Areas, 2020
- TB by Origin of Birth: United States and the District of Columbia, 2020
- TB by Age Group: Metropolitan Statistical Areas with ≥500,000 Population, 2020
- TB by Race/Ethnicity: Metropolitan Statistical Areas with ≥500,000 Population, 2020
- TB by Origin of Birth: Metropolitan Statistical Areas with ≥500,000 Population, 2020
- TB Risk Factors: Reporting Areas, 2020
- TB in Correctional Facilities, Ages ≥15 Years: Reporting Areas, 2020
- TB in Persons Experiencing Homelessness, Ages ≥15 Years: Reporting Areas, 2020
- TB in Long–Term Care Facilities, Ages ≥15 Years: Reporting Areas, 2020
- TB Among Injection Drug Users, Ages ≥15 Years: Reporting Areas, 2020
- TB Among Noninjection Drug Users, Ages ≥15 Years: Reporting Areas, 2020
- TB Among Persons with Excess Alcohol Use, Ages ≥15 Years: Reporting Areas, 2020
- TB by Primary Occupation, Ages ≥15 Years: Reporting Areas, 2020
- TB by HIV Status: Reporting Areas, 2020
- TB by Initial Drug Regimen: Reporting Areas, 2020
- Directly Observed Therapy (DOT): Reporting Areas, 2018
- Reason TB Therapy Was Stopped: Reporting Areas, 2018
- Reason TB Therapy Was Extended: Reporting Areas, 2018
- Completion of TB Therapy (COT): Reporting Areas, 2018
- Persons Completing Therapy for Whom Therapy Was Indicated for ≤1 Year: Reporting Areas, 2014–2018